Considerations in designing systems for large scale production of human cardiomyocytes from pluripotent stem cells.
about
Conjoint propagation and differentiation of human embryonic stem cells to cardiomyocytes in a defined microcarrier spinner cultureG-protein Coupled Receptor Signaling in Pluripotent Stem Cell-derived Cardiovascular Cells: Implications for Disease ModelingGeneration of highly purified human cardiomyocytes from peripheral blood mononuclear cell-derived induced pluripotent stem cellsGenome-Wide Transcriptome and Binding Sites Analyses Identify Early FOX Expressions for Enhancing Cardiomyogenesis Efficiency of hESC Cultures.Challenges in identifying the best source of stem cells for cardiac regeneration therapyImproved Human Pluripotent Stem Cell Attachment and Spreading on Xeno-Free Laminin-521-Coated Microcarriers Results in Efficient Growth in Agitated CulturesEnabling consistency in pluripotent stem cell-derived products for research and development and clinical applications through material standards.Cell-based therapies for cardiac disease: a cellular therapist's perspective.Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?Nano-Enabled Approaches for Stem Cell-Based Cardiac Tissue Engineering.High-throughput downstream process development for cell-based products using aqueous two-phase systems (ATPS) - A case study.A chemical approach to myocardial protection and regeneration.Cardiovascular regeneration.Cell Separation in Aqueous Two-Phase Systems - Influence of Polymer Molecular Weight and Tie-Line Length on the Resolution of Five Model Cell Lines.Therapeutic Use of Stem Cells for Myocardial Infarction.
P2860
Q21999310-940D99C6-2E4A-4EE7-A624-910AFBD353E2Q26772221-3A4D4D52-D2BB-4CF4-A6B1-E4A7D91510C5Q27307424-B591E3C5-3360-409B-A7E5-E6D285846C60Q27319765-098680CD-6126-4C6D-97CC-4C42351783B3Q28083859-820B0CE6-2E28-41E7-AC7C-451007A6DCF9Q30661607-41AE097F-04D2-406E-AA8C-69B1D4BADBC5Q35119693-26EAA6AD-B45D-49AC-BBBC-C834BCA88D89Q38241994-68AD6F24-FB3A-4C0A-97E8-92CB0CBA381EQ38819976-E6602D01-8E5C-4DF6-9D5B-9EBD4E286CD8Q38839098-60374E30-A1C0-4E0A-B071-64587EB82B96Q39156613-AD8D1B38-66EB-4BB0-8306-C1FAF5119D87Q39323701-96083704-8699-4E44-9AAE-9FFCC1DB2D13Q43074474-A582ACFD-E311-4C89-BFCB-512D2754AC5AQ47178676-429BFA8D-06E8-4933-BFA9-D99A30397AB5Q52593734-69417D7D-52F8-4A69-B36D-33A5BAAE3CEF
P2860
Considerations in designing systems for large scale production of human cardiomyocytes from pluripotent stem cells.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Considerations in designing sy ...... s from pluripotent stem cells.
@en
type
label
Considerations in designing sy ...... s from pluripotent stem cells.
@en
prefLabel
Considerations in designing sy ...... s from pluripotent stem cells.
@en
P2093
P2860
P921
P356
P1476
Considerations in designing sy ...... s from pluripotent stem cells.
@en
P2093
Allen Chen
Jasmin Seow
Shaul Reuveny
Sherwin Ting
P2860
P2888
P356
10.1186/SCRT401
P577
2014-01-21T00:00:00Z
P5875
P6179
1010327220